NOVABAY PHARMACEUTICALS INC (NBY) Stock News

NovaBay Pharmaceuticals to Hold Special Meeting of Stockholders

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Mentions: AZTR OGEN XNCR EYPT ...

NovaBay Pharmaceuticals Completes the Sale of its Eyecare Business to PRN and Further Adjourns its Special Meeting of Stockholders on Dissolution Proposal

Why NovaBay Pharmaceuticals (NBY) Stock Is Down 60%

NovaBay Pharmaceuticals shares are trading lower by 61% during Friday's session. The company announced the pricing of its public offering.

NovaBay Pharmaceuticals Announces the Further Adjournment of the Special Meeting of Stockholders

NovaBay CEO Letter to Stockholders Urges a FOR Vote at Upcoming Reconvened Special Meeting

NovaBay Pharmaceuticals to Reconvene Special Meeting of Stockholders on December 18, 2024

Prominent Independent Proxy Advisory Firm ISS Supports NovaBay Pharmaceuticals’ Proposals to Authorize the Sale of its Avenova Brand

NovaBay Pharmaceuticals Reports Third Quarter 2024 Financial Results

NovaBay Pharmaceuticals Accepts Revised Offer from PRN Physician Recommended Nutriceuticals, LLC and Enters into an Amendment to the Asset Purchase Agreement to Increase Purchase Price

NovaBay Pharmaceuticals Board Determines Unsolicited Offer is Superior to Asset Purchase Agreement with PRN Physician Recommended Nutriceuticals, LLC

NBY Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of NovaBay Pharmaceuticals, Inc.’s Avenova Brand and Business Is Fair to Shareholders

NovaBay Pharmaceuticals Signs Definitive Agreement to Sell its Avenova Assets

NBY Stock Earnings: NovaBay Pharmaceuticals Misses EPS, Misses Revenue for Q2 2024

NBY stock results show that NovaBay Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.

NovaBay Pharmaceuticals Reports Second Quarter 2024 Financial Results

NovaBay Pharmaceuticals to Hold Second Quarter 2024 Conference Call on August 13, 2024

NovaBay Pharmaceuticals Reports Record Amazon Prime Day Sales

NovaBay Pharmaceuticals Announces Closing of $3.87 Million Underwritten Public Offering, Including Partial Exercise of Overallotment Option

NovaBay Pharmaceuticals Announces Pricing of $3.5 Million Underwritten Public Offering

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

Pre-market stock movers are worth diving into this morning as we check out all of the hottest news investors need to know about on Friday!

Mentions: WINT BFI CREV EVRI ...

NovaBay Pharmaceuticals Offers 20% Discounts on Avenova Eyecare Products During Amazon Prime Day

NovaBay Pharmaceuticals Reports Preliminary Second Quarter 2024 Net Revenue of $2.4 Million

NovaBay Pharmaceuticals and Eyenovia Commence Co-Promotion Activities

Mentions: EYEN

NovaBay Pharmaceuticals Supports National Dry Eye Awareness Month with Multiple Avenova Product Promotions

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

Pre-market stock movers are worth checking out as we dive into all of the biggest news sending shares higher and lower on Wednesday morning!

Mentions: GDHG WLGS MICS CTM ...

NovaBay Pharmaceuticals Plan of Compliance Accepted by the NYSE American